advanced search

GI/ORAL

THE EMERGENCE OF CONTROLLED-RELEASE POWDERS FOR ORAL ADMINISTRATION
GI/ORAL
Dr Cory Berkland
THE EMERGENCE OF CONTROLLED-RELEASE POWDERS FOR ORAL ADMINISTRATION
Cory Berkland and Nathan Dormer look at what controlled-release powder delivery systems can offer, noting that a rising number of pharmaceutical companies and manufacturing organisations are incorporating controlled-release powder manufacturing to their portfolios.
THIN FILM EVOLVES TO LEVERAGE MUCOSAL DRUG DELIVERY BENEFITS
GI/ORAL
Megan Greth
THIN FILM EVOLVES TO LEVERAGE MUCOSAL DRUG DELIVERY BENEFITS
Megan Greth and Scott Barnhart describe how thin film drug delivery systems are growing in importance as the benefits, such as improved drug bioavailability, reduced adverse events and avoidance of the first pass metabolism, are increasingly being recognised.
DIAL THE DOSE: A CLEVER DISPENSER FOR NON-STERILE LIQUIDS
GI/ORAL
Paul Wismer
Stevanato Group
DIAL THE DOSE: A CLEVER DISPENSER FOR NON-STERILE LIQUIDS
Paul Wismer explains how Balda's Dial-the-Dose product can help  avoid the dangers of accidental overdose from using teaspoon- or tablespoon-based instructions for liquid medications,  highlighted in several reports and studies, by improving the accuracy of liquid dosing.
NOVEL ORAL DRUG DELIVERY: INNOVATING TO SIMPLIFY
GI/ORAL
Rashmi Nair
NOVEL ORAL DRUG DELIVERY: INNOVATING TO SIMPLIFY
Rashmi Nair and Praveen Raheja use case studies to illustrate their company’s approach to simplifying existing oral drug delivery systems, including osmotic and matrix tablet technologies.
A NOVEL APPROACH TO THE ORAL DELIVERY OF BIOLOGICS, PEPTIDES AND ANTIBODIES
EXPERT VIEW
Mir Imran
A NOVEL APPROACH TO THE ORAL DELIVERY OF BIOLOGICS, PEPTIDES AND ANTIBODIES
Mir Imran provides an exclusive update on his company's groundbreaking robotic Auto-Pill™, which delivers a pain-free intestinal injection using a dissolvable needle made from materials that can be absorbed or easily passed out of the body. 
ORAL THIN FILMS – REALMS OF POSSIBILITY?
GI/ORAL
Dr Rick Chan
LTS
ORAL THIN FILMS – REALMS OF POSSIBILITY?
Rick Chan, PhD, Executive Scientific Officer, LTS Lohmann Therapy Systems, discusses the fundamentals of transmucosal absorption and how formulation effort and the drug properties influence drug absorption in the buccal cavity.
WHY ORAL DISINTEGRATING TABLETS?
GI/ORAL
Dr Carmen Popescu
Roquette
WHY ORAL DISINTEGRATING TABLETS?
Carmen Popescu provides an overview of the Orally Disintegrating Tablet (ODT) landscape, describing how these dosage forms can be used to improve and differentiate drug products, different manufacturing methods and how this class of oral delivery system might be applied in the future.
METHODOLOGIES FOR DEVELOPING s-SEDDS
GI/ORAL
Dr John Tillotson
METHODOLOGIES FOR DEVELOPING s-SEDDS
John Tillotson looks at the various methods available for manufacturing solid self-emulsifying drug delivery systems (s-SEDDS) and explores future possibilities of optimising these methods, which are growing in popularity as they offer advantages over liquids.
SMART PILL DISPENSER – A NEW TOOL FOR IMPROVING PATIENT ADHERENCE
CONNECTIVITY
Paul Wismer
Stevanato Group
SMART PILL DISPENSER – A NEW TOOL FOR IMPROVING PATIENT ADHERENCE
Non-adherence by patients to dosing regimens is a major problem and it is estimated that around 50% of people with chronic disease do not take their medications regularly. This has major costs not only financially but also in increased rates of complications and higher morbidity and mortality.
DR ELIZABETH SHEN, COLORCON
INTERVIEW
Dr Elizabeth Shen
Colorcon
DR ELIZABETH SHEN, COLORCON
Elizabeth Shen talks taste-masking, from the positive impact on medication adherence, to technical approaches and technology selection, and regulatory considerations.
MIR IMRAN, RANI THERAPEUTICS
INTERVIEW
Mir Imran
MIR IMRAN, RANI THERAPEUTICS
Mir Imran speaks with ONdrugDelivery Magazine in detail about the innovative “Robotic Pill” technology, currently under development by Rani Therapeutics.
OPTIMISING DRUG DELIVERY: THE CHALLENGES AND OPPORTUNITIES
EXPERT VIEW
Patrick Crowley
OPTIMISING DRUG DELIVERY: THE CHALLENGES AND OPPORTUNITIES
Patrick Crowley and Professor Luigi G Martini discuss the challenges and opportunities in developing drug delivery methods today and in the future.
WHAT DO CUSTOMERS NEED IN ORAL DOSE DEVELOPMENT?
GI/ORAL
Chris Halling
Catalent Pharma Solutions
WHAT DO CUSTOMERS NEED IN ORAL DOSE DEVELOPMENT?
Chris Halling describes the translation of a drug design concept through to the development of an oral dosage form that satisfies the needs of the manufacturer, physicians and patients.
ORAL PEPTIDE DELIVERY: TECHNOLOGY LANDSCAPE & CURRENT STATUS
EXPERT VIEW
Dr Leila N Hassani
ORAL PEPTIDE DELIVERY: TECHNOLOGY LANDSCAPE & CURRENT STATUS
Leila N Hassani, Andy Lewis and Joël Richard provide an overview of the advantages provided, and challenges faced, by oral peptide delivery.
A SOFT AND “SOLVENT-FREE” COATING PROCESS
GI/ORAL
Dr Hubert Lochard
A SOFT AND “SOLVENT-FREE” COATING PROCESS
Hubert Lochard describes the company’s proprietary supercritical fluid coating process Formulcoat®, and its application in taste-masking in particular orodispersible tablet formulation.
Top